Helen Sabzevari Precigen, Inc. (PGEN) insider trading activity

PGEN Quotes by TradingView

Helen Sabzevari is President and CEO of PRECIGEN, INC.. Currently has a direct ownership of 2.22 Million shares of PGEN, which is worth approximately $2 Million. The most recent transaction as insider was on Jan 05, 2021, when has been sold 500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.22M
0% 3M change
42.38% 12M change
Total Value Held $2 Million

Helen Sabzevari Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2021
BUY
Exercise of conversion of derivative security
-
500,000 Added 35.33%
915,259 Common Stock
Jan 04 2021
SELL
Open market or private sale
$53,635 $10.16 p/Share
5,279 Reduced 1.28%
406,632 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
-
17,667 Added 4.0%
424,299 Common Stock
Jan 02 2021
BUY
Exercise of conversion of derivative security
-
9,766 Added 2.32%
411,911 Common Stock

Also insider at

KNTE
Kinnate Biopharma Inc. Healthcare
HS

Helen Sabzevari

President and CEO
Germantown, MD

Track Institutional and Insider Activities on PGEN

Follow PRECIGEN, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PGEN shares.

Notify only if

Insider Trading

Get notified when an Precigen, Inc. insider buys or sells PGEN shares.

Notify only if

News

Receive news related to PRECIGEN, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PGEN